Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.48)
# 245
Out of 5,182 analysts
563
Total ratings
51.59%
Success rate
21.98%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $27 → $37 | $19.16 | +93.11% | 17 | Jan 9, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $16.88 | +18.48% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $2.35 | +112.77% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $566.99 | -11.82% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $180.67 | +7.38% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $7.72 | +55.44% | 18 | Jul 29, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $6.29 | +265.66% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $86.68 | -30.78% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $22.30 | +43.50% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $426.01 | +29.10% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $135.98 | -11.75% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.60 | +400.00% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $5.16 | -61.24% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $37.34 | -6.27% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $10.79 | +29.75% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $33.71 | +3.83% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $6.10 | +129.51% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $45.33 | +65.45% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $18.04 | +110.64% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $11.01 | +127.07% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $19.94 | +60.48% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.90 | +237.08% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $20.39 | -21.53% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $10.29 | +133.24% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.84 | +322.54% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $128.64 | -70.46% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $128.04 | +31.21% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $2.52 | +336.51% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.25 | +135.29% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $6.94 | +217.00% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $33.59 | -40.46% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.49 | +705.37% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.21 | +149.52% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.20 | +34.15% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $4.99 | +360.92% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.31 | +1,045.04% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $29.27 | +19.58% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $10.08 | +644.05% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.83 | +147.35% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.33 | +651.88% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.61 | +24,490.16% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $13.93 | +330.73% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $1.58 | +849.37% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.86 | +4,545.22% | 3 | Mar 16, 2022 |
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $27 → $37
Current: $19.16
Upside: +93.11%
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $16.88
Upside: +18.48%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $2.35
Upside: +112.77%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $566.99
Upside: -11.82%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $180.67
Upside: +7.38%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $7.72
Upside: +55.44%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $6.29
Upside: +265.66%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $86.68
Upside: -30.78%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $22.30
Upside: +43.50%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $426.01
Upside: +29.10%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $135.98
Upside: -11.75%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.60
Upside: +400.00%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $5.16
Upside: -61.24%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $37.34
Upside: -6.27%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $10.79
Upside: +29.75%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $33.71
Upside: +3.83%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $6.10
Upside: +129.51%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $45.33
Upside: +65.45%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $18.04
Upside: +110.64%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $11.01
Upside: +127.07%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $19.94
Upside: +60.48%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $8.90
Upside: +237.08%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $20.39
Upside: -21.53%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $10.29
Upside: +133.24%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.84
Upside: +322.54%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $128.64
Upside: -70.46%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $128.04
Upside: +31.21%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $2.52
Upside: +336.51%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $4.25
Upside: +135.29%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $6.94
Upside: +217.00%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $33.59
Upside: -40.46%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.49
Upside: +705.37%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.21
Upside: +149.52%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $8.20
Upside: +34.15%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $4.99
Upside: +360.92%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.31
Upside: +1,045.04%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $29.27
Upside: +19.58%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $10.08
Upside: +644.05%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.83
Upside: +147.35%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $1.33
Upside: +651.88%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.61
Upside: +24,490.16%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $13.93
Upside: +330.73%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $1.58
Upside: +849.37%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.86
Upside: +4,545.22%